Sustained off-treatment efficacy despite barzolvolimab clearance and normalization of tryptase, suggesting disease modification in patients ...

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...

Merck & Co.'s Keytruda in combination with an antibody-drug conjugate from Pfizer and Astellas Pharma led to a 47% reduction in the risk of tumor recurrence, progression or death in patients with ...

Researchers reveal that eosinophils suppress chordoma growth, highlighting its potential as an immunotherapeutic target ...

Add Yahoo as a preferred source to see more of our stories on Google. "People are getting more and more lonely in this digital world. And I think that's what is driving this," Sriraam Natarajan, Ph.D.

(Pew Research Center photo illustration; photos by curly_photo, Justin Sullivan, Alex Kent and Paul Bradbury, all via Getty Images) The Pew-Knight Initiative supports new research on how Americans ...

MEDLINE, EMBASE, and Cochrane Library were searched from inception to January 2026. Observational studies evaluating periodontitis (diagnosed clinically, serologically, or via periodontal indices) and ...

Adding Merck & Co. and Moderna’s vaccine candidate to Keytruda has continued to cut the risk of cancer recurrence or death across five years of follow-up, boosting the companies’ prospects as they ...

To investigate the relationship between circulatory stasis in the left atrial appendage (LAA), as detected by cardiac computed tomography angiography, and atrial fibrillation (AF) recurrence after the ...

Greenwich LifeSciences Inc. (NASDAQ: GLSI) stock is trading higher on Monday, with a session volume of 2.804 million compared to the average volume of 81.85 thousand, as per data from Benzinga Pro.

Artificial intelligence (AI) has impacted how GTM teams sell and engage buyers in the past year, resulting in marketing teams taking greater ownership of revenue strategy and the buyer relationship.